A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase

Sakurikar, N., Thompson, R., Montano, R. et al. (1 more author) (2015) A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase. Oncotarget, 7. pp. 1380-1394.

Abstract

Metadata

Authors/Creators:
  • Sakurikar, N.
  • Thompson, R.
  • Montano, R.
  • Eastman, A.
Copyright, Publisher and Additional Information: © Impact Journals. Licensed under a Creative Commons Attribution 3.0 License.
Dates:
  • Published: 22 November 2015
  • Accepted: 16 November 2015
  • Published (online): 22 November 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Jul 2017 10:48
Last Modified: 25 Jul 2017 10:48
Published Version: http://doi.org/10.18632/oncotarget.6364
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.6364

Download

Share / Export

Statistics